|
The document discusses a 3M study revealing elevated organic fluorine levels in the blood plasma of employees involved in the manufacture of fluorosurfactants, indicating potential exposure sources and the initiation of a special medical program for current workers, while noting that the specific products implicated are not manufactured at the Chambers Works facility.
|
— |
AR226-3416
|
Z44q5O7zKaXaJJnoDqZZb4Grd |
2 |